P
Pharmala Biotech Holdings Inc
CNSX:MDMA
Pharmala Biotech Holdings Inc
CNSX:MDMA
Price:
0.1
CAD
Market Cap:
CA$10.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Pharmala Biotech Holdings Inc
CNSX:MDMA
|
CA |
|
COSCO SHIPPING Development Co Ltd
OTC:CITAF
|
CN |
|
Arihant Superstructures Ltd
NSE:ARIHANTSUP
|
IN |
|
R
|
Roche Holding AG
DUS:RHO
|
CH |
|
Champion Microelectronic Corp
TWSE:3257
|
TW |
|
T
|
TAG Colonia Immobilien AG
XHAM:KBU
|
DE |
|
Green Mining Innovation Inc
XTSX:GMI
|
CA |
Income Statement
Earnings Waterfall
Pharmala Biotech Holdings Inc
Pharmala Biotech Holdings Inc
Income Statement
Pharmala Biotech Holdings Inc
Pharmala Biotech Holdings Inc
Currency: CAD
| Feb-2022 | May-2022 | Aug-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
+11%
|
0
+119%
|
0
-41%
|
1
+427%
|
1
+141%
|
1
0%
|
1
+11%
|
1
-27%
|
0
-67%
|
0
+16%
|
0
-1%
|
1
+55%
|
1
+25%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
+10%
|
0
N/A
|
0
N/A
|
0
+6 296%
|
1
+81%
|
1
+11%
|
1
+15%
|
1
-15%
|
0
-45%
|
1
+9%
|
1
-2%
|
1
+6%
|
1
+21%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(3)
N/A
|
(1)
+69%
|
(1)
-4%
|
(0)
+52%
|
(1)
-28%
|
(1)
-29%
|
(0)
+63%
|
(0)
-53%
|
(1)
-17%
|
(1)
-31%
|
(1)
-97%
|
(2)
-43%
|
(2)
-6%
|
(2)
-8%
|
(2)
+5%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(3)
N/A
|
(1)
+69%
|
(1)
-4%
|
(0)
+52%
|
(1)
-28%
|
(1)
-29%
|
(0)
+42%
|
(1)
-33%
|
(1)
-12%
|
(1)
-21%
|
(1)
-63%
|
(2)
-44%
|
(2)
-6%
|
(2)
-7%
|
(2)
+3%
|
|
| Net Income | ||||||||||||||||
| Income from Continuing Operations |
(3)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Net Income (Common) |
(3)
N/A
|
(1)
+69%
|
(1)
-4%
|
(0)
+52%
|
(1)
-28%
|
(1)
-29%
|
(0)
+42%
|
(1)
-33%
|
(1)
-12%
|
(1)
-21%
|
(1)
-63%
|
(2)
-44%
|
(2)
-6%
|
(2)
-7%
|
(2)
+3%
|
|
| EPS (Diluted) |
-0.04
N/A
|
-0.01
+75%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
